Stay updated on Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-10T14:17:05.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The update is a minor revision from v3.4.1 to v3.4.2 with no visible user-facing changes to the study details on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-16T23:58:56.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1; removed the funding-lapse notice and Revision: v3.4.0.
    Difference
    0.3%
    Check dated 2026-02-09T20:27:17.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata to display Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-26T14:55:40.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4 with no user-visible changes; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-19T07:47:44.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Locations were reorganized into a consolidated Locations section with multiple state entries. Per-state location headers were removed, the HHS Vulnerability Disclosure was deleted, and the page revision updated to v3.3.3.
    Difference
    0.9%
    Check dated 2025-12-20T22:01:36.000Z thumbnail image

Stay in the know with updates to Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.